Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US58506Q1094
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG0065B7K59
MEDP
Medpace Holdings Inc
GICS: Health Care · SECTOR: Healthcare · SUB-SECTOR: Diagnostics & Research · THEMEFOLIO: $HLTH
NAME
Medpace Holdings Inc
ISIN
US58506Q1094
TICKER
MEDP
MIC
XNAS
REUTERS
MEDP.OQ
BLOOMBERG
MEDP US
Sun, 26.04.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - April 26, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpa...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Sun, 26.04.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Sat, 25.04.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - April 25, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpa...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 24.04.2026       Medpace
US58506Q1094

NEW YORK, April 24, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 24.04.2026       Medpace
US58506Q1094

LOS ANGELES, April 24, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP)....
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 24.04.2026       Medpace
US58506Q1094

Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Medpace Holdings Inc. (NASDAQ:MEDP) and certain of the Company’s senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Me...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 24.04.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 23.04.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) and reminds investors of the June 8, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. This pres...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 23.04.2026       Medpace
US58506Q1094

Key Dates and Disclosure Events Shareholders Need to KnowNEW YORK, April 23, 2026 /PRNewswire/ -- SueWallSt encourages investors who suffered losses in Medpace Holdings Inc. (NASDAQ: MEDP) to contact the firm. Those who purchased Medpace securities between April 22, 2025 and February 9, 2026 may be entitled to recover damages. Find out if you are...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 23.04.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - April 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpa...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Wed, 22.04.2026       Medpace
US58506Q1094

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Results Revenue for the three months ended March 31, 2026 increased 26.5% to $706.6 million, compared to $558.6 million for the comparable prior-year period. On a constant currency basis,...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 22.04.2026       Medpace
US58506Q1094

BENSALEM, Pa., April 22, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN MEDPACE HOLDINGS, INC. (MEDP),...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 22.04.2026       Medpace
US58506Q1094

Promise vs. Reality: The Medpace Performance GapNEW YORK, April 22, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP highlights the contrast between Medpace Holdings Inc.'s (NASDAQ: MEDP) promises and results. Find out if you can recover your investment losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500....
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 22.04.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - April 21, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpa...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 22.04.2026       Medpace
US58506Q1094

SAN DIEGO, April 21, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), have until June 8, 2026 to seek appointment as lead plaintiff of the Medpace class action lawsuit. Ca...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 21.04.2026       Medpace
US58506Q1094

Levi & Korsinsky, LLP notifies investors that Jesse J. Geiger, President of Medpace Holdings Inc. (NASDAQ: MEDP), is named as a defendant in a securities class action covering purchases between April 22, 2025 and February 9, 2026. Find out if you qualify to recover losses from the MEDP securities action. You may also contact Joseph E. Levi, Esq...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 21.04.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner J...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 21.04.2026       Medpace
US58506Q1094

NEW YORK, April 21, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Medpace Holdings, Inc. (NASDAQ: MEDP). Shareholders who purchased shares of MEDP during the class period listed are encouraged...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 21.04.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - April 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpa...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 21.04.2026       Medpace
US58506Q1094

NEW YORK, April 20, 2026 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Mon, 20.04.2026       Medpace
US58506Q1094

Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Medpace Holdings Inc. (NASDAQ: MEDP) securities between April 22, 2025 and February 9, 2026. Medpace is a clinical contract research organization (CRO) focused on providing scientifically driven outsourced clinical developme...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 20.04.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 20.04.2026       Medpace
US58506Q1094

San Diego, California--(Newsfile Corp. - April 20, 2026) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), have until June 8, 2026 to seek appointment as lead plaintiff of the...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 20.04.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - April 19, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline.SO WHAT: If you purchased Medpa...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Sat, 18.04.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 16.04.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - April 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed....
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 16.04.2026       Medpace
US58506Q1094

LOS ANGELES, April 16, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP) have opportunity to lead the securities fraud class action lawsuit....
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 16.04.2026       Medpace
US58506Q1094

NEW YORK, April 16, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 16.04.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner J...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 16.04.2026       Medpace
US58506Q1094

Deadline Alert: Understanding Lead Plaintiff Selection Under the PSLRANEW YORK, April 16, 2026 /PRNewswire/ -- IMPORTANT DATE: June 8, 2026. Investors who purchased Medpace Holdings Inc. (NASDAQ: MEDP) securities between April 22, 2025 and February 9, 2026 and wish to seek appointment as lead plaintiff must file a motion by this date. Shares lost...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 15.04.2026       Medpace
US58506Q1094

SAN DIEGO, April 15, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, both dates inclusive (the "Class Period"), have until June 8, 2026 to seek appointment as lead plaintiff of the Medpace class action...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 15.04.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 15.04.2026       Medpace
US58506Q1094

Notice to Pension Funds, Asset Managers, and FiduciariesNEW YORK, April 15, 2026 /PRNewswire/ -- Institutional investors holding positions in Medpace Holdings Inc. (NASDAQ: MEDP) during the period April 22, 2025 through February 9, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Wed, 15.04.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - April 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed....
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 14.04.2026       Medpace
US58506Q1094

Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming June 8, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, inclusive (th...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 14.04.2026       Medpace
US58506Q1094

LOS ANGELES, April 14, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by th...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Tue, 14.04.2026       Medpace
US58506Q1094

LOS ANGELES, April 14, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareho...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 13.04.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 13.04.2026       Medpace
US58506Q1094

Law Offices of Howard G. Smith reminds investors of the upcoming June 8, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, inclusive (the “Class Period”). IF YOU ARE AN IN...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Mon, 13.04.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - April 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed....
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Sun, 12.04.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Sat, 11.04.2026       Medpace
US58506Q1094

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, both dates inclusive (the “Class Period”), have until June 8, 2026 to seek appointment as lead plaintiff of the Medpace class action lawsuit. Captioned Durbin...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 10.04.2026       Medpace
US58506Q1094

SAN DIEGO, April 10, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"), have until June 8, 2026 to seek appointment as lead plaintiff of the Medpace class ac...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 10.04.2026       Medpace
US58506Q1094

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, inclusiv...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 10.04.2026       Medpace
US58506Q1094

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Medpace between April 22, 2025 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner J...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Fri, 10.04.2026       Medpace
US58506Q1094

Lead Plaintiff Deadline June 5, 2026NEW YORK, April 10, 2026 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed against Medpace Holdings, Inc. ("Medpace" or the Company") (NASDAQ: MEDP) in the United States District Court for the Southern District of Ohio on behalf of all persons and...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 09.04.2026       Medpace
US58506Q1094

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, inclusive (the “Class Period”). Medpace investors have until June 8, 2026 to file a lead plaintiff motio...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 09.04.2026       Medpace
US58506Q1094

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) common stock between April 22, 2025 and February 9, 2026, inclusive (the “Class Period”). Medpace investors have until June 5, 2026 to...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 09.04.2026       Medpace
US58506Q1094

New York, New York--(Newsfile Corp. - April 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025 and February 9, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. I...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink
Thu, 09.04.2026       Medpace
US58506Q1094

NEW YORK, April 9, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail ar...
Read more
Medpace
Technical Analysis Termsheets Terminal
Permalink